Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 13/20 | 0.74 |
| ▸ | TMPRSS11D | O60235 | 9/20 | 0.59 |
| ▸ | F10 | P00742 | 2/20 | 0.58 |
| ▸ | PLG | P00747 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15077024 | 1.00 | F2 (0.74) | F2TMPRSS11DF10PLG | |
| SCHEMBL23752316 | 1.00 | F2 (0.74) | F2TMPRSS11DF10PLG | |
| Hydrochloric Acid SCHEMBL7357933 | 0.99 | F2 (0.73) | F2TMPRSS11DF10PLG | |
| Hydrochloric Acid SCHEMBL7147479 | 0.99 | F2 (0.73) | F2TMPRSS11DF10PLG | |
| SCHEMBL23793876 | 0.94 | F2 (0.65) | F2TMPRSS11DF10PLG | |
| SCHEMBL21067756 | 0.91 | DPP4 (0.61) | F2 | |
| SCHEMBL21067758 | 0.91 | DPP4 (0.61) | F2 | |
| SCHEMBL7102905 | 0.91 | F2 (0.61) | F2TMPRSS11D | |
| Acetic Acid SCHEMBL6482237 | 0.90 | F2 (0.76) | F2TMPRSS11DF10PLG | |
| SCHEMBL7460022 | 0.89 | F2 (0.58) | F2TMPRSS11D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361212-A1 | Peptide derivatives as antithrombotic agents | AstraZeneca AB (SE) | 2003-11-12 | — | — | EP | claimed |
| EP-0672658-A1 | Antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-09-20 | — | — | EP | claimed |
| WO-1995023609-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1995-09-08 | — | — | WO | claimed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |